These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9463986)

  • 21. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs.
    Taha AS; Angerson WJ; Prasad R; McCloskey C; Gilmour D; Morran CG
    Aliment Pharmacol Ther; 2008 Oct; 28(7):878-85. PubMed ID: 18644010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
    Rahme E; Nedjar H; Bizzi A; Morin S
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic imaging of NSAID ulcers].
    Ono S; Kato M; Asaka M; Ono Y; Yokoyama A
    Nihon Rinsho; 2007 Oct; 65(10):1792-800. PubMed ID: 17926526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gastrointestinal complications of nonsteroidal anti-inflammatory drugs and low-dose aspirin].
    Thiéfin G
    Gastroenterol Clin Biol; 2003 May; 27(5):498-510. PubMed ID: 12843912
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The risk factors for aspirin induced peptic ulcer].
    Shiotani A; Kamada T; Manabe N; Imamura H; Haruma K
    Nihon Rinsho; 2010 Nov; 68(11):2015-9. PubMed ID: 21061525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chan FK
    Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Low-dose aspirin (LDA)/nonsteroidal anti-inflammatory drugs(NSAIDs)-induced gastrointestinal injury in Japan].
    Sugano K
    Nihon Rinsho; 2011 Jun; 69(6):977-81. PubMed ID: 21688615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-steroidal anti-inflammatory drugs and peptic ulcer.
    Langman MJ
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():37-9. PubMed ID: 1577395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in the diagnostic yield of upper gastrointestinal endoscopy in dyspeptic patients receiving proton-pump inhibitors and H2-receptor antagonists.
    Mitchell RM; Collins JS; Watson RG; Tham TC
    Endoscopy; 2002 Jul; 34(7):524-6. PubMed ID: 12170401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Legido J; García-Sanz I; Pajares JM
    Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of prevention.
    Scheiman JM
    Rev Gastroenterol Disord; 2005; 5 Suppl 2():39-49. PubMed ID: 16369226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma.
    Tsibouris P; Hendrickse MT; Isaacs PE
    Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical aspects and course of drug-induced upper digestive hemorrhage].
    Tournut R; Pascal JP; Frexinos J; Suduca P; Legrand G; Benarous JJ; Ribet A
    Sem Hop; 1976 Nov; 52(40):2283-9. PubMed ID: 188180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
    Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of commonly used non steroidal anti-inflammatory drugs on gastric mucosa. A clinical, endoscopic and histopathological study.
    Misra R; Pandey H; Chandra M; Chandra M; Agarwal PK; Pandeya SN
    J Assoc Physicians India; 1990 Sep; 38(9):636-8. PubMed ID: 2266080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
    Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM
    Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.